Abstract
Objective: In early-stage endometrioid endometrial cancer (EC) patients who are fertile, fertility-sparing therapy is enforced than primary surgical staging. However, there is no consensus for the optimal duration of this treatment. The aim of this study is to determine the duration of fertility-sparing hormone therapy in patients with early-stage endometrioid EC.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
